Article info
Research
Low-dose ketamine adjuvant treatment for refractory pain in children, adolescents and young adults with cancer: a pilot study
- Correspondence to Dr Perrine Marec-Berard, Unité de Traitement de la Douleur de l' Enfant, Centre Leon Berard, Lyon 69373, France; perrine.marec-berard{at}ihope.fr
Citation
Low-dose ketamine adjuvant treatment for refractory pain in children, adolescents and young adults with cancer: a pilot study
Publication history
- Received December 10, 2018
- Revision received April 11, 2019
- Accepted May 1, 2019
- First published May 31, 2019.
Article Versions
- Previous version (31 May 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.